Natalie Cook (N Cook)

Scopus Author ID ResearcherID Scopus Author ID Scopus Author ID Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 19

Top Topics

Health Insurance

Childhood Cancer

Top Venues

British journal of cancer

Nature communications

Clinical cancer research : an official journal of the American Association for Cancer Research

NPJ genomic medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Alicia-Marie Conway, Simon P Pearce, Alexandra Clipson, Steven M Hill, Francesca Chemi, Dan Slane-Tan, Saba Ferdous, A S Md Mukarram Hossain, Katarzyna Kamieniecka, Daniel J White, Claire Mitchell, Alastair R W Kerr, Matthew G Krebs, Gerard Brady, Caroline Dive, Natalie Cook, Dominic G Rothwell
A cfDNA methylation-based tissue-of-origin classifier for cancers of unknown primary. Nature communications 15 (1) (2024)
S Rae, S Shaya, E Taylor, J Hoben, D Oluwashegun, H Lowe, N Haris, S Bashir, C Oing, M G Krebs, F C Thistlethwaite, L Carter, Natalie Cook, A Greystoke, D M Graham, R Plummer
Social determinants of health inequalities in early phase clinical trials in Northern England. British journal of cancer 131 (4) (2024)
Alicia-Marie Conway, Simon P Pearce, Alexandra Clipson, Steven M Hill, Francesca Chemi, Dan Slane-Tan, Saba Ferdous, A S Md Mukarram Hossain, Katarzyna Kamieniecka, Daniel J White, Claire Mitchell, Alastair R W Kerr, Matthew G Krebs, Gerard Brady, Caroline Dive, Natalie Cook, Dominic G Rothwell
A cfDNA methylation-based tissue-of-origin classifier for cancers of unknown primary. Nature communications 15 (1) (2024)
Alicia-Marie Conway, Simon P Pearce, Alexandra Clipson, Steven M Hill, Francesca Chemi, Dan Slane-Tan, Saba Ferdous, A S Md Mukarram Hossain, Katarzyna Kamieniecka, Daniel J White, Claire Mitchell, Alastair R W Kerr, Matthew G Krebs, Gerard Brady, Caroline Dive, Natalie Cook, Dominic G Rothwell
A cfDNA methylation-based tissue-of-origin classifier for cancers of unknown primary. Nature communications 15 (1) (2024)
Alicia-Marie Conway, Simon P Pearce, Alexandra Clipson, Steven M Hill, Francesca Chemi, Dan Slane-Tan, Saba Ferdous, A S Md Mukarram Hossain, Katarzyna Kamieniecka, Daniel J White, Claire Mitchell, Alastair R W Kerr, Matthew G Krebs, Gerard Brady, Caroline Dive, Natalie Cook, Dominic G Rothwell
A cfDNA methylation-based tissue-of-origin classifier for cancers of unknown primary. Nature communications 15 (1) (2024)
S Rae, S Shaya, E Taylor, J Hoben, D Oluwashegun, H Lowe, N Haris, S Bashir, C Oing, M G Krebs, F C Thistlethwaite, L Carter, Natalie Cook, A Greystoke, D M Graham, R Plummer
Social determinants of health inequalities in early phase clinical trials in Northern England. British journal of cancer 131 (4) (2024)
S Rae, S Shaya, E Taylor, J Hoben, D Oluwashegun, H Lowe, N Haris, S Bashir, C Oing, M G Krebs, F C Thistlethwaite, L Carter, Natalie Cook, A Greystoke, D M Graham, R Plummer
Social determinants of health inequalities in early phase clinical trials in Northern England. British journal of cancer (2024)
S Rae, S Shaya, E Taylor, J Hoben, D Oluwashegun, H Lowe, N Haris, S Bashir, C Oing, M G Krebs, F C Thistlethwaite, L Carter, Natalie Cook, A Greystoke, D M Graham, R Plummer
Social determinants of health inequalities in early phase clinical trials in Northern England. British journal of cancer 131 (4) (2024)
Valentine Moya Macaulay, Simon R Lord, Syed Anwer Hussain, José Pablo Maroto, Robert Hugh Jones, Miguel Ángel Climent, Natalie Cook, Chia-Chi Lin, Shian-Shiang Wang, Diletta Bianchini, Mark Bailey, Laura Schlieker, Thomas Bogenrieder, Johann de Bono
A Phase Ib/II study of IGF-neutralising antibody xentuzumab with enzalutamide in metastatic castration-resistant prostate cancer. British journal of cancer (2023)
Eleni Domzaridou, Tjeerd Pieter van Staa, Andrew G Renehan, Natalie Cook, William Welfare, Darren M Ashcroft, Victoria Palin
The Impact of Oral Antibiotics Prior to Cancer Diagnosis on Overall Patient Survival: Findings from an English Population-Based Cohort Study. Current oncology (Toronto, Ont.) 30 (9) (2023)
Alicia-Marie Conway, Georgina C Morris, Sarah Smith, Monique Vekeria, Prakash Manoharan, Claire Mitchell, Alison Backen, Pedro Oliveira, Richard A Hubner, Angela Lamarca, Mairéad Geraldine McNamara, Juan W Valle, Natalie Cook
Intrahepatic cholangiocarcinoma hidden within cancer of unknown primary. British journal of cancer 127 (3) (2022)
Susana Banerjee, Vasiliki Michalarea, Joo Ern Ang, Alvaro H Ingles Garces, Andrea Biondo, Ionut-Gabriel Funingana, Martin Little, Ruth Ruddle, Florence I Raynaud, Ruth Riisnaes, Bora Gurel, Sue Chua, Nina Tunariu, Joanna C Porter, Toby Prout, Mona Parmar, Anna Zachariou, Alison Turner, Ben Jenkins, Stuart McIntosh, Ed Ainscow, Anna R Minchom, Juanita Lopez, Johann S de Bono, Robert Jones, Emma C Hall, Natalie Cook, Bristi Basu, Udai Banerji
A Phase I Trial of CT900, a Novel α-Folate Receptor-Mediated Thymidylate Synthase Inhibitor, in Patients with Solid Tumors with Expansion Cohorts in Patients with High-Grade Serous Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (21) (2022)
Ann Tivey, Matt Church, Dominic Rothwell, Caroline Dive, Natalie Cook
Circulating tumour DNA - looking beyond the blood. Nature reviews. Clinical oncology 19 (9) (2022)
Atish D Choudhury, Celestia S Higano, Johann S de Bono, Natalie Cook, Dana E Rathkopf, Kari B Wisinski, Juan Martin-Liberal, Mark Linch, Elisabeth I Heath, Richard D Baird, Javier García Corbacho, Miguel Quintela-Fandino, Simon T Barry, Elza C de Bruin, Steve Colebrook, George Hawkins, Teresa Klinowska, Brijesh Maroj, Ganesh Moorthy, Peter G S Mortimer, Michele Moschetta, Myria Nikolaou, Liz Sainsbury, Geoffrey I Shapiro, Lillian L Siu, Aaron Richard Hansen
A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3Kβ/δ, in Patients with Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (11) (2022)
Bethany Geary, Erin Peat, Sarah Dransfield, Natalie Cook, Fiona C Thistlethwaite, Donna Graham, Louise Carter, Andrew Hughes, Matthew G Krebs, Anthony D Whetton
Discovery and Evaluation of Protein Biomarkers as a Signature of Wellness in Late-Stage Cancer Patients in Early Phase Clinical Trials. Cancers 13 (10) (2021)
Thomas Powles, Danielle Carroll, Simon Chowdhury, Gwenaelle Gravis, Florence Joly, Joan Carles, Aude Fléchon, Pablo Maroto, Daniel Petrylak, Frédéric Rolland, Natalie Cook, Arjun V Balar, Srikala S Sridhar, Matthew D Galsky, Petros Grivas, Alain Ravaud, Robert J Jones, Jan Cosaert, Darren Hodgson, Iwanka Kozarewa, Richard Mather, Robert McEwen, Florence Mercier, Dónal Landers
An adaptive, biomarker-directed platform study of durvalumab in combination with targeted therapies in advanced urothelial cancer. Nature medicine 27 (5) (2021)
Debbie G J Robbrecht, Juanita Lopez, Emiliano Calvo, Xiaomin He, Hirai Hiroshi, Nital Soni, Natalie Cook, Afshin Dowlati, Angelica Fasolo, Victor Moreno, Ferry A L M Eskens, Johann S de Bono
A first-in-human phase 1 and pharmacological study of TAS-119, a novel selective Aurora A kinase inhibitor in patients with advanced solid tumours. British journal of cancer 124 (2) (2020)
Alicia-Marie Conway, Claire Mitchell, Elaine Kilgour, Gerard Brady, Caroline Dive, Natalie Cook
Molecular characterisation and liquid biomarkers in Carcinoma of Unknown Primary (CUP): taking the 'U' out of 'CUP'. British journal of cancer 120 (2) (2018)
Pedro Torres Ayuso, Sudhakar Sahoo, Garry Ashton, Elvira An, Nicole Simms, Melanie Galvin, Hui Sun Leong, Kristopher K Frese, Kathryn Simpson, Natalie Cook, Andrew Hughes, Crispin J Miller, Richard Marais, Caroline Dive, Matthew G Krebs, John Brognard
Signaling pathway screening platforms are an efficient approach to identify therapeutic targets in cancers that lack known driver mutations: a case report for a cancer of unknown primary origin. NPJ genomic medicine 3 (2018)